Otsuka Pharmaceutical Launches POCARI SWEAT in India, Strengthening Global Nutraceutical Expansion Otsuka Pharmaceutical Co., Ltd. (Otsuka) has officially launched sales of its popular health drink, POCARI SWEAT, in India as…
Astellas Reports Preliminary U.S. Sales of IZERVAY™ Reach ¥15.9 Billion ($110 Million) in Q1 FY2025 Astellas Pharma , a leading global pharmaceutical company under the leadership of President and CEO…
The Longevity Revolution: Six Biotech Startups Transforming How We Age Armed with cutting-edge biological science, advanced computational tools, and deep-pocketed investors, a new wave of biotech startups is targeting what…
FDA Approves Label Update for Lilly’s Alzheimer’s Drug Kisunla in Bid to Enhance Safety and Broaden Use The U.S. Food and Drug Administration (FDA) has approved a significant label update…
Trump Floats 200% Tariffs on Pharma Imports, Offers Industry One-Year Grace Period In a move that could significantly reshape the pharmaceutical supply chain and global drug trade, President Donald Trump…
Supreme Court Halts Injunction, Allowing RFK Jr.’s HHS Workforce Cuts to Move Forward The U.S. Supreme Court on Tuesday issued a stay that permits the Trump administration to proceed with…
Merck Bolsters Respiratory Portfolio With $10B Verona Acquisition Ahead of Keytruda Patent Cliff In the second-largest biopharma acquisition of 2025, Merck is acquiring Verona Pharma for $10 billion, a strategic…
AstraZeneca’s Alexion Taps JCR Pharmaceuticals for Gene Therapy Capsids in Deal Worth Up to $825M AstraZeneca’s rare disease unit, Alexion, is deepening its partnership with Japan-based JCR Pharmaceuticals through a…
Nuclidium Secures $99M Series B to Advance Copper-Based Radiopharma Platform Swiss biotech Nuclidium has raised approximately $99 million in a Series B funding round to accelerate the development of its…
Merck to Acquire Verona Pharma in $10 Billion Deal, Adding Ohtuvayre® to Strengthen Respiratory Portfolio and Expand Long-Term Growth in COPD Market Merck & Co., known as MSD outside the…
FDA Greenlights Label Update and Revised Dosing Schedule for Lilly’s Kisunla (donanemab‑azbt) in Early Symptomatic Alzheimer’s Eli Lilly and Company today announced that the U.S. Food and Drug Administration (FDA)…
ICON Celebrated for Clinical Research Leadership, Innovation, and Sustainability in 2025 a global leader in healthcare intelligence and clinical research, has received widespread industry recognition during the first half of…
